About the Company
We do not have any company description for Vir Biotechnology, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $VIR News
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors
Vir Biotechnology, Inc. (“Vir” or “the Company”, Nasdaq: VIR) today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its ...
Can investing in infectious disease pay off? Vir Biotechnology’s tightrope walk shows it’s a struggle
Vir Biotechnology's founders threw millions at infectious disease. Covid made them look like geniuses. The road since then ...
How Vir found the one: CEO Marianne De Backer
Vir Biotechnology conducted a worldwide search to find the perfect CEO. In the end, the board picked Bayer’s Marianne De Backer, Ph.D., because of her three decades of experience in the ...
Vir Biotechnology CFO Sung Lee to step down in May
Vir Biotechnology Inc . (NASDAQ:VIR) announced Monday that Executive Vice President and Chief Financial Officer Sung Lee will resign from his position effective May 3, 2024. Lee is leaving to ...
Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the first quarter e ...
Vir Biotechnology nominates two new board members
SAN FRANCISCO - Vir Biotechnology, Inc. (NASDAQ:VIR), an immunology company specializing in infectious diseases, announced the nomination of two new independent directors to its Board of Directors.
Vir Biotechnology Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors
SAN FRANCISCO, April 18, 2024--(BUSINESS WIRE)--Vir Biotechnology, Inc. ("Vir" or "the Company", Nasdaq: VIR) today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid ...
Vir Biotechnology nominates two new board members
SAN FRANCISCO - Vir Biotechnology, Inc. (NASDAQ:VIR), an immunology company specializing in infectious diseases, announced the nomination of two new independent directors to its Board of Directors. If ...
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors
Vir Biotechnology, Inc. (“Vir” or “the Company”, Nasdaq: VIR) today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors (the “Board ...
Loading the latest forecasts...